Buscar
Mostrando ítems 1-10 de 42
Third-trimester erythrocytapheresis in pregnant patients with sickle cell disease
(Elsevier Ireland LtdClareIrlanda, 2007)
Uso de factor VII en el control de sangrados perioperatorios: Evidencias actuales
(Sociedad Médica de Santiago, 2009)
Factores asociados a aloinmunización en pacientes hospitalizados en la Fundación Cardioinfantil de 2014 a 2017
(Universidad del RosarioMaestría en EpidemiologíaMaestría en Actividad Física y Salud, 2019)
Introduction: Alloimmunization is a complication to transfusion, it has been observed that the rates have increased considerably over time. There are different factors that cause some patients to alloimmunize and others ...
Estado nutricional relativo ao ferro em lactentes com doença falciforme diagnosticoados pelo Programa Estadual de Triagem Neonatal de Minas Gerais
(Universidade Federal de Minas GeraisUFMG, 2009-09-21)
Iron deficiency anemia is the most common nutritional disease in the world. Sickle cell disease is the most common inherited monogenic disease, characterized by a defect in the hemoglobin molecule. As this disease may be ...
Avaliação da compatibilidade eritrocitária para reduzir a aloimunização em mulheres portadoras de Anemia Falciforme
(Universidade Federal de São Paulo, 2022-08-09)
Introdução: A anemia falciforme (AF) é a hemoglobinopatia mais frequente no Brasil e
afeta principalmente indivíduos de origem africana. Na anemia falciforme, a gestação
possui um risco materno fetal elevado e a ...
Perioperative Temporary Occlusion of the Internal Iliac Arteries as Prophylaxis in Cesarean Section at Risk of Hemorrhage in Placenta Accreta
(SPRINGER, 2011)
Purpose The purpose of this study was to describe the preliminary results of prophylactic temporary balloon occlusion of the internal iliac arteries for bleeding control in patients with placenta accreta during cesarean ...
Iron deficiency in Brazilian infants with sickle cell disease
(Soc Brasil Pediatria, 2011-09-01)
Objective: To assess iron deficiency or overload in infants with sickle cell disease in order to support the decision to recommend (or not) iron prophylactic supplementation in this population.Methods: Cross-sectional and ...
Hemofilia : terapéutica en las alteraciones hemostáticas. Parte I
(2014-02-03)
Las hemofilias A y B son coagulopatías congénitas que afectan aproximadamente a 5,000
colombianos; la hemofilia A es la más común. En el pasado, el tratamiento de la hemofilia
con productos sanguíneos produjo un aumento ...